Host-pathogen evolution: Implications for the prevention and treatment of malaria, myocardial infarction and AIDS

Medical Hypotheses

Volumn 70, Issue 1, 2008, Pages 21-25

  Foster, Harold D ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ACETYLCYSTEINE; CYSTEINE; GLUTAMINE; RETINOL; SELENIUM; SELENOMETHIONINE; SODIUM SELENITE; TRACE ELEMENT; TRYPTOPHAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COXSACKIE VIRUS B; DISEASE PREDISPOSITION; GENETIC VARIABILITY; HEART INFARCTION; HOST PATHOGEN INTERACTION; HUMAN; MALARIA; MOLECULAR EVOLUTION; NONHUMAN; NUTRIENT; NUTRITIONAL SUPPORT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SELENIUM DEFICIENCY; SOUTH AFRICA; SYMPTOMATOLOGY; UGANDA; ZAMBIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CHILD; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MALARIA; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; PLASMODIUM FALCIPARUM;

HUMAN ENTEROVIRUS B; HUMAN IMMUNODEFICIENCY VIRUS 1; PLASMODIUM FALCIPARUM;

EID: 36348966520     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.05.008     Document Type: Article

References (39)

1. Ewald P.W. Plague time: the new germ theory of disease (2002), Anchor Books, New York
2. Krause R.M. The origin of plagues: old and new. Science 257 5073 (1992) 1073-1078
3. Neu H.C. The crisis in antibiotic resistance. Science 257 5073 (1992) 1064-1073
4. Foster H.D. A role for the antioxidant defense system in preventing the transmission of HIV. Med Hypotheses 69 (2007) 1277-1280
5. Foster H.D. AIDS and the "selenium-CD4T cell tailspin". The Geography of a pandemic. Townsend Lett Doct Patients 209 (2000) 94-99
6. Teugwa M.C., Zofu D., and Amvam Z.P.H. Effects of Vitamin A and iron supplementation on the treatment of malaria in Cameroonian preschool children. J Trop Med 3 1 (2006) 1-11
7. Shankar A.H., Genton B., Semba R.D., Baisor M., Paino J., Jamja S., et al. Effect of Vitamin A supplementation on morbility due to Plasodium falciparum in young children in Papua New Guinea: a randomized trial. Lancet 354 9174 (1999) 203-209
8. John Hopkins Bloomberg School of Public Health. Public Health News Centre. Vitamin A cuts children's malaria risk by nearly a third. .
9. Villamor E., Mbise R., Spiegelman D., Hertzmark E., Fataki M., Peterjon K.E., et al. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth. Pediatrics 109 1 (2002) E6
10. Mizuno Y., Kawazu S.I., Kano S., Watanabe N., Matsuura T., and Ohtomo H. In vitro uptake of Vitamin A by Plasodium falciparum. Ann Trop Med Parasitol 97 3 (2003) 237-243
11. Weeks B.S. Vitamin A and beta-carotene. J Orthomol Med 18 3-4 (2003) 131-145
12. Titiyal J.S., Pal N., Murthy G.V., Gupta S.K., Tandon R., Vajpayee R.B., et al. Causes and temporal trends of blindness and severe visual impairment in children in schools for the blind in North India. Brit J Ophthalmol 87 8 (2003) 941-945
13. Carme B., Bouquety J.C., and Plassart H. Mortality and sequelae due to cerebral malaria in African children in Brazzaville, Congo. Am J Trop Med Hyg 48 2 (1993) 216-221
14. Cox S.E., Staalsoe T., Arthur P., Bulmer J.N., Tagbor H., Hviia L., et al. Maternal Vitamin A supplementation and immunity to malaria in pregnancy in Ghanaian primigravids. Trop Med Int Health 10 12 (2005) 1287-1297
15. Nicholl A.C., and Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet 1 (1977) 883-884
16. Kipshidze N.N., Chapidze G.E., and Lapidus M.I. Characteristics of the course of myocardial infarct in patients with a history of Coxsackie B viral infection. Vrach Dalo August 8 (1988) 31-34
17. Friman G., and Fohlman J. The epidemiology of viral heart disease. Scand J Infect Dis Suppl 88 (1993) 7-10
18. Kok F.J., Hofman A., Witteman J.C.M., de Bruijin M., Kruyssen D.H., de Bruin M., et al. Decreased selenium levels in acute myocardial infarction. JAMA 261 8 (1989) 1161-1164
19. Saporito F., Micari A., Raffa S., Cerrito M., Micari G., and Grassi R. Acute myocardial infarction and rescue percutaneous transluminal coronary angioplasty in a young HIV-infected patient. Int J Clin Pract 59 3 (2005) 376-378
20. Ogunro P.S., Ogungbamigbe T.O., Elemie P.O., Egbewale B.E., and Adewole T.A. Plasma selenium concentration and glutathione peroxidase activity in HIV/AIDS infected patients: a correlation with disease progression. Niger Postgrad Med J 13 1 (2006) 1-5
21. Zhang W., Ramanathan C.S., Nadimpallli R.G., Bhat A.A., Cox A.G., and Taylor E.W. Selenium dependent glutathione peroxidase modules encoded by RNA viruses. Biol Trace Elem Res 70 2 (1999) 97-116
22. Cermelli C., Vincet M., Scaltriti E., Bazzani E., Beretti F., Vivoli G., et al. Selenium inhibition of Coxsackie B5 replication on the etiology of Keshan disease. J Trace Elem Med Biol 16 1 (2002) 41-46
23. 10 and antioxidants in acute myocardial infarction. Mol Aspects Med 15 Suppl (1994) S143-S147
24. Foster H.D. Coxsackie B virus and myocardial infarction. Lancet 359 9308 (2002) 804
25. Foster H.D. How HIV-causes AIDS: implications for prevention and treatment. Med Hypotheses 62 4 (2004) 549-553
26. Foster H.D. What really causes AIDS (2002), Trafford Publishing, Victoria, BC
27. Foster H.D. Halting the AIDS pandemic. In: Janelle D.G., Warf B., and Hansen K. (Eds). WorldMinds: geographical perspectives on 100 problems (2004), Kluver Academic Publishers, Dordrecht 69-73
28. Cenac A., Simonoff M., Moretto P., and Djibo A. A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. Int J Cardiol 36 1 (1992) 57-59
29. Van Ryssen J., and Bradfield G. An assessment of the selenium, copper and zinc status in sheep on cultivated pastures in the Natal Midlands. J S Afr Vet Med Assoc 63 4 (1992) 56-61
30. UNAIDS/WHO 2002 HIV/AIDS Documentation. .
31. Foster H.D. AIDS in Finland. J Orthomol Med 20 3 (2005) 221-222
32. Kameoka M., Okada Y., Tobiume M., Kimura T., and Ikuta K. Intracellular glutathione as a possible direct blocker of HIV type 1 reverse transcription. AIDS Res Hum Retrovirus 12 17 (1996) 1635-1638
33. Baum M.K., Shor-Posnor G., Lai S., Zhang G., Lai H., Fletcher M.A., et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immuno Defic Syndr Hum Retrovirol 15 3 (1997) 370-374
34. Droge W. Cycteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetyl-cysteine. Pharmacology 46 2 (1993) 61-65
35. Shabert J.K., Winslow C., Lacey J.M., and Wilmore D.W. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized double-blind controlled trial. Nutrition 15 11-12 (1999) 860-864
36. Werner E.R., Fuchs D., Hausen A., Jaeger H., Reibnegger G., Werner-Felmayer G., et al. Tryptophan degradation in patients infected by human immunodeficiency virus. Biol Chem Hoppe Seyler 369 5 (1988) 337-340
37. Bradfield M., and Foster H.D. The successful orthomol treatment of AIDS: accumulating evidence from Africa. J Orthomol Med 21 4 (2006) 193-196
38. Taylor E.W., Bhat A., Nadimpall R.G., Zhang W., and Kececioglu J. HIV-1 encodes a sequence overlapping env gp41 with highly significant similarity to selenium-dependent glutathione peroxidase. J AIDS Hum Retrovirus 15 5 (1997) 393-395
39. Taylor E.W. Selenium and viral diseases: facts and hypotheses. J Orthomol Med 12 4 (1997) 227-239